Key applications of RPP12 RPMI 1640 Medium (Modification 12) include:
  • Cultivation of lymphocytes for immune response studies
  • Expansion of hybridoma cells for monoclonal antibody production
  • Maintenance of cancer cell lines for drug screening and therapeutic studies
  • Supporting primary cell cultures for various in vitro experiments
Supported animal cell types include:
  • Human peripheral blood lymphocytes (PBLs)
  • Mouse splenocytes
  • Human epithelial carcinoma cells (e.g., HeLa)
  • Chinese hamster ovary (CHO) cells
  • Jurkat T cells
By this medium, researchers can enhance their experimental outcomes, driving innovations in biotechnology and medical research.
**Disclaimer:** Results may vary depending on specific cell lines, specifications, and experimental conditions. Consult with cell culture specialists and review comprehensive literature to tailor RPP12’s use to your specific research needs.